AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The FDA's REMS Program for Psilocybin
For psilocybin, for MDMA, the drug is not the therapy. It's the psychotherapy. And I think the FDA doesn't regulate psychotherapy. They don't understand psychotherapy. We're having some problems with the FDA because they've indicated that in our phase three studies and our phase two studies, we have a two-person therapy team,. The lead person is a licensed therapist. The second person is a student even learning to get a license.